147 related articles for article (PubMed ID: 36727949)
1. Waiting to Operate: The Risk of Salvage Esophagectomy.
Boerner T; Harrington C; Tan KS; Adusumilli PS; Bains MS; Bott MJ; Downey RJ; Huang J; Ilson DH; Isbell JM; Janjigian YY; Park BJ; Rocco G; Rusch VW; Sihag S; Wu AJ; Jones DR; Molena D
Ann Surg; 2023 May; 277(5):781-788. PubMed ID: 36727949
[TBL] [Abstract][Full Text] [Related]
2. Salvage esophagectomy after failed definitive chemoradiation for esophageal adenocarcinoma.
Marks JL; Hofstetter W; Correa AM; Mehran RJ; Rice D; Roth J; Walsh G; Vaporciyan A; Erasmus J; Chang J; Maru D; Lee JH; Lee J; Ajani JA; Swisher SG
Ann Thorac Surg; 2012 Oct; 94(4):1126-32; discussion 1132-3. PubMed ID: 22921233
[TBL] [Abstract][Full Text] [Related]
3. It's not always too late: a case for minimally invasive salvage esophagectomy.
Broderick RC; Lee AM; Blitzer RR; Zhao B; Lam J; Cheverie JN; Sandler BJ; Jacobsen GR; Onaitis MW; Kelly KJ; Bouvet M; Horgan S
Surg Endosc; 2021 Aug; 35(8):4700-4711. PubMed ID: 32940794
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.
Wong AT; Shao M; Rineer J; Lee A; Schwartz D; Schreiber D
Ann Surg; 2017 Jun; 265(6):1146-1151. PubMed ID: 27280504
[TBL] [Abstract][Full Text] [Related]
5. Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer.
Visser E; Leeftink AG; van Rossum PS; Siesling S; van Hillegersberg R; Ruurda JP
Ann Surg Oncol; 2016 Aug; 23(8):2679-89. PubMed ID: 27012988
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Factors of Salvage Esophagectomy for Residual or Recurrent Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy.
Kiyozumi Y; Yoshida N; Ishimoto T; Yagi T; Koga Y; Uchihara T; Sawayama H; Hiyoshi Y; Iwatsuki M; Baba Y; Miyamoto Y; Watanabe M; Matsuyama T; Oya N; Baba H
World J Surg; 2018 Sep; 42(9):2887-2893. PubMed ID: 29423738
[TBL] [Abstract][Full Text] [Related]
7. Postoperative Pneumonia is Associated with Long-Term Oncologic Outcomes of Definitive Chemoradiotherapy Followed by Salvage Esophagectomy for Esophageal Cancer.
Takeuchi M; Kawakubo H; Mayanagi S; Yoshida K; Fukuda K; Nakamura R; Suda K; Wada N; Takeuchi H; Kitagawa Y
J Gastrointest Surg; 2018 Nov; 22(11):1881-1889. PubMed ID: 29980971
[TBL] [Abstract][Full Text] [Related]
8. Survival risk prediction model for patients with pT
Qi Z; Hu Y; Qiu R; Li J; Li Y; He M; Wang Y
J Cardiothorac Surg; 2021 May; 16(1):121. PubMed ID: 33933129
[TBL] [Abstract][Full Text] [Related]
9. Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial.
Nuytens F; Dabakuyo-Yonli TS; Meunier B; Gagnière J; Collet D; D'Journo XB; Brigand C; Perniceni T; Carrère N; Mabrut JY; Msika S; Peschaud F; Prudhomme M; Markar SR; Piessen G;
JAMA Surg; 2021 Apr; 156(4):323-332. PubMed ID: 33595631
[TBL] [Abstract][Full Text] [Related]
10. Prognosis after neoadjuvant chemoradiation or chemotherapy for locally advanced gastro-oesophageal junctional adenocarcinoma.
Vos EL; Carr RA; Hsu M; Nakauchi M; Nobel T; Russo A; Barbetta A; Tan KS; Tang L; Ilson D; Ku GY; Wu AJ; Janjigian YY; Yoon SS; Bains MS; Jones DR; Coit D; Molena D; Strong VE
Br J Surg; 2021 Nov; 108(11):1332-1340. PubMed ID: 34476473
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
12. The effect of postoperative complications on survival of patients after minimally invasive esophagectomy for esophageal cancer.
Li KK; Wang YJ; Liu XH; Tan QY; Jiang YG; Guo W
Surg Endosc; 2017 Sep; 31(9):3475-3482. PubMed ID: 27924395
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of post-photodynamic therapy salvage esophagectomy in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Shigeno T; Kajiyama D; Sato K; Fujiwara N; Kinugasa Y; Yano T; Daiko H; Fujita T
Esophagus; 2023 Oct; 20(4):643-650. PubMed ID: 37391597
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology.
Stiles BM; Kamel MK; Harrison SW; Rahouma M; Lee B; Nasar A; Port JL; Altorki NK
Ann Thorac Surg; 2019 Jan; 107(1):187-193. PubMed ID: 30278165
[TBL] [Abstract][Full Text] [Related]
15. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer.
Sharaiha RZ; Halazun KJ; Mirza F; Port JL; Lee PC; Neugut AI; Altorki NK; Abrams JA
Ann Surg Oncol; 2011 Nov; 18(12):3362-9. PubMed ID: 21547702
[TBL] [Abstract][Full Text] [Related]
16. Incidence and management of esophageal cancer recurrence to regional lymph nodes after curative esophagectomy.
Boerner T; Carr RA; Hsu M; Michel A; Tan KS; Vos E; Sihag S; Bains MS; Ku GY; Wu AJ; Jones DR; Molena D
Int J Cancer; 2023 May; 152(10):2109-2122. PubMed ID: 36573352
[TBL] [Abstract][Full Text] [Related]
17. Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study.
Luc G; Gronnier C; Lebreton G; Brigand C; Mabrut JY; Bail JP; Meunier B; Collet D; Mariette C
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1357-64. PubMed ID: 26014152
[TBL] [Abstract][Full Text] [Related]
18. Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma.
Hsu PK; Huang CS; Wang BY; Wu YC; Hsu WH
Ann Thorac Surg; 2014 May; 97(5):1734-41. PubMed ID: 24612702
[TBL] [Abstract][Full Text] [Related]
19. The survival impact of postoperative complications after curative resection in patients with esophageal squamous cell carcinoma: propensity score-matching analysis.
Yamamoto M; Shimokawa M; Yoshida D; Yamaguchi S; Ohta M; Egashira A; Ikebe M; Morita M; Toh Y
J Cancer Res Clin Oncol; 2020 May; 146(5):1351-1360. PubMed ID: 32185488
[TBL] [Abstract][Full Text] [Related]
20. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
